NEU neuren pharmaceuticals limited

FDA, page-3

  1. 1,003 Posts.
    lightbulb Created with Sketch. 174
    A contrarian view and one not outside the realms of possibility, is that big players knew in advance of the drugs pending approval and sold down shares on the news to scare the retail market into offloading so they could pick up at a significant discount. That's the conspiracy theorist in me purely surmising

    https://www.biopharmadive.com/news/billy-dunn-fda-depart-agency-neuroscience-alzheimers/643627/

    https://hotcopper.com.au/data/attachments/5109/5109091-585681c4f959dde7c97c3c9a3dfd37cd.jpg



    Last edited by Saus: 08/03/23
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.59
Change
0.230(1.60%)
Mkt cap ! $1.816B
Open High Low Value Volume
$14.49 $14.61 $14.32 $3.030M 209.1K

Buyers (Bids)

No. Vol. Price($)
1 1030 $14.55
 

Sellers (Offers)

Price($) Vol. No.
$14.60 4030 4
View Market Depth
Last trade - 16.10pm 15/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.